Pentoxifylline in hepatopulmonary syndrome

doi:10.3748/wjg.v18.i35.4912

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3242)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-3) series.

Item

Count

PDF

663

HTML

2390

Tables (1-3)

189

Sum=3242

Sep 21, 2012 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 21, 2012; 18(35): 4912-4916
Published online Sep 21, 2012. doi: 10.3748/wjg.v18.i35.4912

Table 3 PaO₂, SaO₂ and alveolar-arterial oxygen gradient (A-a G) before, at the end and 3 mo after treatment among patients who could tolerate pentoxifylline (mean ± SD)

Variables	PaO₂	SaO₂	A-a G
Baseline	73.3 ± 9.33	93.33 ± 6.28	40.10 ± 18.09
End of treatment	97.0 ± 3.79	97.66 ± 1.50	20.73 ± 9.46
Three months after treatment	71.83 ± 21.47	90.5 ± 8.6	43.68 ± 24.30
P value	0.02¹, 0.02²	0.04¹, 0.05²	0.02¹, 0.02²

¹Baseline vs end of treatment;

²End of treatment vs 3 mo later. PaO₂: Oxygen pressure; SaO₂: Oxygen saturation.

Citation: Kianifar HR, Khalesi M, Mahmoodi E, Afzal Aghaei M. Pentoxifylline in hepatopulmonary syndrome. World J Gastroenterol 2012; 18(35): 4912-4916
URL: https://www.wjgnet.com/1007-9327/full/v18/i35/4912.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i35.4912